KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calix (CALX) Cash & Equivalents (2016 - 2026)

Calix filings provide 17 years of Cash & Equivalents readings, the most recent being $54.6 million for Q1 2026.

  • Quarterly Cash & Equivalents rose 29.08% to $54.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $54.6 million through Mar 2026, up 29.08% year-over-year, with the annual reading at $143.1 million for FY2025, 231.51% up from the prior year.
  • Cash & Equivalents hit $54.6 million in Q1 2026 for Calix, down from $143.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $143.1 million in Q4 2025 and bottomed at $42.3 million in Q1 2025.
  • Average Cash & Equivalents over 5 years is $77.9 million, with a median of $76.5 million recorded in 2025.
  • The largest annual shift saw Cash & Equivalents crashed 54.04% in 2024 before it skyrocketed 231.51% in 2025.
  • Calix's Cash & Equivalents stood at $79.1 million in 2022, then decreased by 19.81% to $63.4 million in 2023, then plummeted by 31.93% to $43.2 million in 2024, then skyrocketed by 231.51% to $143.1 million in 2025, then plummeted by 61.84% to $54.6 million in 2026.
  • Per Business Quant, the three most recent readings for CALX's Cash & Equivalents are $54.6 million (Q1 2026), $143.1 million (Q4 2025), and $95.0 million (Q3 2025).